1. Home
  2. DLY vs EMBC Comparison

DLY vs EMBC Comparison

Compare DLY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleLine Yield Opportunities Fund of Beneficial Interest

DLY

DoubleLine Yield Opportunities Fund of Beneficial Interest

HOLD

Current Price

$14.65

Market Cap

707.0M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$11.54

Market Cap

719.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLY
EMBC
Founded
2019
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
707.0M
719.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DLY
EMBC
Price
$14.65
$11.54
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
215.9K
664.0K
Earning Date
01-01-0001
11-25-2025
Dividend Yield
8.93%
5.20%
EPS Growth
N/A
20.90
EPS
N/A
1.62
Revenue
N/A
$1,080,400,000.00
Revenue This Year
N/A
$2.18
Revenue Next Year
N/A
$0.09
P/E Ratio
N/A
$7.12
Revenue Growth
N/A
N/A
52 Week Low
$13.26
$9.20
52 Week High
$15.95
$21.23

Technical Indicators

Market Signals
Indicator
DLY
EMBC
Relative Strength Index (RSI) 51.28 33.78
Support Level $14.53 $11.02
Resistance Level $14.67 $12.56
Average True Range (ATR) 0.11 0.74
MACD 0.03 -0.22
Stochastic Oscillator 79.59 12.97

Price Performance

Historical Comparison
DLY
EMBC

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: